ACP Journal Club. Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality
- PMID: 22508742
- DOI: 10.7326/0003-4819-156-8-201204170-02002
ACP Journal Club. Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality
Comment on
-
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7. Ann Intern Med. 2011. PMID: 21984740 Review.
Similar articles
-
ACP Journal Club. Review: Prostate cancer screening using PSA does not decrease mortality.Ann Intern Med. 2011 Jan 18;154(2):JC1-2. doi: 10.7326/0003-4819-154-2-201101180-02002. Ann Intern Med. 2011. PMID: 21242356 No abstract available.
-
ACP Journal Club. Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality.Ann Intern Med. 2012 Jul 17;157(2):JC2-4. doi: 10.7326/0003-4819-157-2-201207170-02004. Ann Intern Med. 2012. PMID: 22801696 No abstract available.
-
ACP Journal Club. Annual screening for prostate cancer did not reduce mortality from prostate cancer.Ann Intern Med. 2009 Jun 16;150(12):JC6-4, JC6-5. doi: 10.7326/0003-4819-150-12-200906160-02004. Ann Intern Med. 2009. PMID: 19528549 No abstract available.
-
[Advancements in PSA-based screening for prostate cancer].Rinsho Byori. 2004 Jul;52(7):611-7. Rinsho Byori. 2004. PMID: 15344561 Review. Japanese.
-
Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.Am J Prev Med. 2008 Feb;34(2):164-70. doi: 10.1016/j.amepre.2007.10.003. Am J Prev Med. 2008. PMID: 18201648 Review.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous